Clinical Trial Update: The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults [EARLY_Phase 1]

View source ↗

Summary

An early-phase study at Ruijin Hospital is investigating treatment for newly diagnosed CD19+ Mixed Phenotype Acute Leukemia in adults. The trial is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Mixed Phenotype Acute Leukemia

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Leukemia | EARLY_Phase 1 | Status: NOT_YET_RECRUITING